Am J Psychiatry 160:167-169, January 2003
© 2003 American Psychiatric Association
Omega-3 Fatty Acid Treatment of Women With Borderline Personality Disorder: A Double-Blind, Placebo-Controlled Pilot Study
Mary C. Zanarini, Ed.D., and
Frances R. Frankenburg, M.D.
OBJECTIVE: The purpose of this study was to compare the efficacy of ethyl-eicosapentaenoic acid (E-EPA) and placebo in the treatment of female subjects with borderline personality disorder. METHOD: The authors conducted an 8-week, placebo-controlled, double-blind study of E-EPA in 30 female subjects meeting Revised Diagnostic Interview for Borderlines and DSM-IV criteria for borderline personality disorder. RESULTS: Twenty subjects were randomly assigned to 1 g of E-EPA; 10 subjects were given placebo. Ninety percent of those in both groups completed all 8 weeks of the trial. Analyses that used random-effects regression modeling and controlled for baseline severity showed E-EPA to be superior to placebo in diminishing aggression as well as the severity of depressive symptoms. CONCLUSIONS: The results of this study suggest that E-EPA may be a safe and effective form of monotherapy for women with moderately severe borderline personality disorder.
This article has been cited by other articles:
|
|
|
|
 
N. Vaisman, N. Kaysar, Y. Zaruk-Adasha, D. Pelled, G. Brichon, G. Zwingelstein, and J. Bodennec
Correlation between changes in blood fatty acid composition and visual sustained attention performance in children with inattention: effect of dietary n-3 fatty acids containing phospholipids
Am. J. Clinical Nutrition,
May 1, 2008;
87(5):
1170 - 1180.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. M Appleton, R. C Hayward, P. J Rogers, D. Gunnell, T. J Peters, D. Kessler, and A. R Ness
Reply to UN Das
Am. J. Clinical Nutrition,
June 1, 2007;
85(6):
1666 - 1666.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. HALLAHAN, J. R. HIBBELN, J. M. DAVIS, and M. R. GARLAND
Omega-3 fatty acid supplementation in patients with recurrent self-harm: Single-centre double-blind randomised controlled trial
The British Journal of Psychiatry,
February 1, 2007;
190(2):
118 - 122.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. M Appleton, R. C Hayward, D. Gunnell, T. J Peters, P. J Rogers, D. Kessler, and A. R Ness
Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: systematic review of published trials
Am. J. Clinical Nutrition,
December 1, 2006;
84(6):
1308 - 1316.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Lee, K. M. Gura, S. Kim, D. A. Arsenault, B. R. Bistrian, and M. Puder
Current Clinical Applications of {Omega}-6 and {Omega}-3 Fatty Acids
Nutr Clin Pract,
August 1, 2006;
21(4):
323 - 341.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Parker, N. A. Gibson, H. Brotchie, G. Heruc, A.-M. Rees, and D. Hadzi-Pavlovic
Omega-3 Fatty Acids and Mood Disorders
Am J Psychiatry,
June 1, 2006;
163(6):
969 - 978.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Tritt, C. Nickel, C. Lahmann, P. K. Leiberich, W. K. Rother, T. H. Loew, and M. K. Nickel
Lamotrigine treatment of aggression in female borderline-patients: a randomized, double-blind, placebo-controlled study
J Psychopharmacol,
May 1, 2005;
19(3):
287 - 291.
[Abstract]
[PDF]
|
|
|
|
|
|
|
F. POUWER, R. LIEVERSE, M. DIAMANT, and J. ASSIES
Schizophrenia, Syndrome X, and Omega-3 Fatty Acids
Am J Psychiatry,
October 1, 2004;
161(10):
1926 - 1926.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Arehart-Treichel
BPD Patients Respond To Omega-3 Fatty Acids
Psychiatr News,
January 17, 2003;
38(2):
17 - 17.
[Full Text]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2003
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
